ACE2 and infection: Unfortunately, the titer of ACE2-RBD neutralizing antibodies and the level of specific MBCs after the second dose of the vaccine were similar in individuals with or without vaccine breakthrough, not supporting the association of these immune responses with protection against infection at least 1 year earlier.